Koers Sansure Biotech Inc.
Aandelen
688289
CNE1000043J1
Medische apparatuur, benodigdheden & distributie
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
18,5 CNY | +0,93% | -0,43% | -5,37% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 10,59 mld. 76,69 mld. 9,89 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
44
x | K/w-verhouding 2025 * |
28,5
x | Werknemers | 2.567 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 46,34% |
1 dag | +0,93% | ||
1 week | -0,43% | ||
Lopende maand | -4,15% | ||
1 maand | -10,63% | ||
3 maanden | +4,93% | ||
6 maanden | +20,13% | ||
Lopend jaar | -5,37% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Li Zhong Dai
CEO | Chief Executive Officer | 56 | 23-04-08 |
Wu Tan
CHM | Chairman | 40 | 01-01-10 |
Zhu Peng
DFI | Director of Finance/CFO | 48 | 01-08-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
You Lin Qiao
BRD | Director/Board Member | 68 | 08-07-19 |
Li Zhong Dai
CEO | Chief Executive Officer | 56 | 23-04-08 |
Xia Lin Yu
BRD | Director/Board Member | 45 | 01-12-08 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
1.04% | 1 M€ | -13,11% | - | |
0.12% | 12 M€ | -16,71% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 18,5 | +0,93% | 3 582 192 |
22-04-24 | 18,33 | -0,33% | 3 164 371 |
19-04-24 | 18,39 | +0,33% | 2 524 284 |
18-04-24 | 18,33 | +0,44% | 4 066 461 |
17-04-24 | 18,25 | +0,33% | 5 440 224 |
slotkoers Shanghai S.E., 23 april 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,37% | 1,45 mld. | |
+0,80% | 12,66 mld. | |
-12,75% | 7,04 mld. | |
+2,81% | 5,39 mld. | |
-1,37% | 4,45 mld. | |
+3,89% | 4,32 mld. | |
-50,71% | 3,31 mld. | |
+9,29% | 2,6 mld. | |
-15,10% | 2,01 mld. | |
-2,82% | 1,67 mld. |